<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Sci Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id>
<journal-title-group>
<journal-title>Scientific Reports</journal-title>
</journal-title-group>
<issn pub-type="epub">2045-2322</issn>
<publisher>
<publisher-name>Nature Publishing Group UK</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29872062</article-id>
<article-id pub-id-type="pmc">5988674</article-id>
<article-id pub-id-type="publisher-id">26814</article-id>
<article-id pub-id-type="doi">10.1038/s41598-018-26814-6</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Intermittent fasting uncovers and rescues cognitive phenotypes in PTEN neuronal haploinsufficient mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5441-1807</contrib-id>
<name>
<surname>Cabral-Costa</surname>
<given-names>J. V.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Andreotti</surname>
<given-names>D. Z.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2343-7884</contrib-id>
<name>
<surname>Mello</surname>
<given-names>N. P.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1206-0882</contrib-id>
<name>
<surname>Scavone</surname>
<given-names>C.</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Camandola</surname>
<given-names>S.</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Kawamoto</surname>
<given-names>E. M.</given-names>
</name>
<address>
<email>kawamotoe@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0722</institution-id><institution-id institution-id-type="GRID">grid.11899.38</institution-id><institution>Laboratory of Molecular and Functional Neurobiology, Department of Pharmacology, Institute of Biomedical Sciences, </institution><institution>University of São Paulo, </institution></institution-wrap>São Paulo, Brazil </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0722</institution-id><institution-id institution-id-type="GRID">grid.11899.38</institution-id><institution>Laboratory of Molecular Neuropharmacology, Department of Pharmacology, Institute of Biomedical Sciences, </institution><institution>University of São Paulo, </institution></institution-wrap>São Paulo, Brazil </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9372 4913</institution-id><institution-id institution-id-type="GRID">grid.419475.a</institution-id><institution>Laboratory of Neurosciences, </institution><institution>NIA, NIH, </institution></institution-wrap>Baltimore, MD USA </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>5</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>5</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>8</volume>
<elocation-id>8595</elocation-id>
<history>
<date date-type="received">
<day>6</day>
<month>12</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>5</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Phosphatase and tensin homolog (PTEN) is an important protein with key modulatory functions in cell growth and survival. PTEN is crucial during embryogenesis and plays a key role in the central nervous system (CNS), where it directly modulates neuronal development and synaptic plasticity. Loss of PTEN signaling function is associated with cognitive deficits and synaptic plasticity impairment. Accordingly, <italic>Pten</italic> mutations have a strong link with autism spectrum disorder. In this study, neuronal <italic>Pten</italic> haploinsufficient male mice were subjected to a long-term environmental intervention – intermittent fasting (IF) – and then evaluated for alterations in exploratory, anxiety and learning and memory behaviors. Although no significant effects on spatial memory were observed, mutant mice showed impaired contextual fear memory in the passive avoidance test – an outcome that was effectively rescued by IF. In this study, we demonstrated that IF modulation, in addition to its rescue of the memory deficit, was also required to uncover behavioral phenotypes otherwise hidden in this neuronal <italic>Pten</italic> haploinsufficiency model.</p>
</abstract>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p id="Par2">Phosphatase and tensin homolog (PTEN) was originally characterized as a tumor suppressor<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup> as it is commonly deleted in several human tumors<sup><xref ref-type="bibr" rid="CR3">3</xref>–<xref ref-type="bibr" rid="CR5">5</xref></sup>. The most well described function of PTEN is as a lipid and protein phosphatase that classically converts 3,4,5-phosphatidylinositol trisphosphate into 4,5-phosphatidylinositol bisphosphate, thus acting as a negative modulator of AKT signaling activation<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. PTEN plays an important modulatory role in cell growth, proliferation and survival and is critical to key processes in animal development<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. Indeed, PTEN knockout mice die precociously during embryogenesis<sup><xref ref-type="bibr" rid="CR8">8</xref>–<xref ref-type="bibr" rid="CR11">11</xref></sup>. Recently, PTEN was shown to potentially act through phosphatase-independent mechanisms<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup>, thus expanding its influence beyond the AKT signaling pathway.</p>
<p id="Par3">In the central nervous system (CNS), PTEN is widely expressed in neurons, particularly in dendritic spines, across several brain areas, including the cerebellum, cortex, hippocampi and olfactory bulb<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. PTEN is crucial for mature neuron survival, playing an important role in neurite extension<sup><xref ref-type="bibr" rid="CR15">15</xref></sup> and modulating cell number, size and migration properties<sup><xref ref-type="bibr" rid="CR16">16</xref>–<xref ref-type="bibr" rid="CR19">19</xref></sup>. <italic>Pten</italic> deletion induces an increase in the size and number of dendrite ramifications and synapses<sup><xref ref-type="bibr" rid="CR20">20</xref>–<xref ref-type="bibr" rid="CR22">22</xref></sup>, culminating in functional synaptic plasticity impairment<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR24">24</xref></sup>. <italic>Pten</italic> mutations have been linked to cognitive deficits in humans<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. Accordingly, mice with neuronal <italic>Pten</italic> deletion showed impaired social interaction and increased anxiety behavior<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR26">26</xref></sup>, thus validating their use to elucidate the role of PTEN in the CNS and cognition, particularly in the study of autism spectrum disorders.</p>
<p id="Par4">Intermittent fasting (IF) is an environmental intervention with known modulatory and neuroprotective effects<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. The regimen consists of alternating days of free access to food with those of complete fasting long term, thus not necessarily affecting the total amount of food consumed but rather the intake frequency<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. In the CNS, IF was shown to improve learning and memory from rats and mouse models through humans<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> and to modulate cognition and synaptic plasticity through changes in the expression profile of glutamatergic ionotropic receptors in mice<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. Therefore, IF is a potent environmental intervention that can be used as a tool to stimulate the CNS as well as potentially rescue impaired function.</p>
<p id="Par5">In this study, we examined the behavioral profile of male mice with neuronal <italic>Pten</italic> haploinsufficiency under IF conditions. We also assessed markers of AKT signaling activity and synaptic and glutamatergic receptor profiles.</p>
</sec>
<sec id="Sec2" sec-type="results">
<title>Results</title>
<sec id="Sec3">
<title>Intermittent fasting induced an intermittent loss of body mass and a decrease in total food consumption</title>
<p id="Par6">When assessed after a period of fasting, animals under IF showed a significantly lower body mass than control animals (P ≤ 0.0001 for control (C)/wild-type (WT) × IF/WT; P ≤ 0.05 for C/heterozygous (HT) × IF/HT), an intermittent effect that was rescued at each following period of <italic>ad libitum</italic> food offering (Fig. <xref ref-type="fig" rid="Fig1">1a</xref>). Interestingly, there was no significant effect on body mass variation induced by the IF regimen (F (1, 71) = 0.3694, P = 0.5453 for the treatment factor; F (1, 71) = 2.289, P = 0.1347 for the genotype factor) (Supplementary Fig. <xref ref-type="media" rid="MOESM1">S1</xref>).<fig id="Fig1"><label>Figure 1</label><caption><p>Body mass and food consumption during the intermittent fasting protocol. (<bold>a</bold>) Body mass curve of the first 30 days of intermittent fasting, two-way ANOVA with repeated measures followed by Holm-Sidak’s post hoc test, <sup>*</sup>P ≤ 0.0001 for C/WT x IF/WT, <sup>#</sup>P ≤ 0.05 for C/HT x IF/HT, n = 14 (IF/HT), 15 (C/WT, C/HT), and 16 (IF/WT); (<bold>b</bold>) average food consumption, two-way ANOVA followed by Holm-Sidak’s post hoc test, <sup>*</sup>P ≤ 0.05, n = 15 (C/WT, IF/WT, IF/HT) and 16 (C/HT).</p></caption><graphic id="d29e414" xlink:href="41598_2018_26814_Fig1_HTML"></graphic></fig></p>
<p id="Par7">Regardless of the genotype, animals under IF consumed significantly less food than control animals (F (1, 56) = 20.45, P ≤ 0.0001 for the treatment factor) (Fig. <xref ref-type="fig" rid="Fig1">1b</xref>). However, this reduction in food intake (on average, 12.1% for C/WT × IF/WT and 15.5% for C/HT × IF/HT) was remarkably modest, considering that the food intake of IF groups was restricted to fed days.</p>
</sec>
<sec id="Sec4">
<title>HT animals displayed a significant increase in total brain and cortical mass</title>
<p id="Par8"><italic>Pten</italic> haploinsufficiency caused an increase in total brain mass compared to the WT condition (F (1, 88) = 46.42, P ≤ 0.0001 for the genotype factor), although no differences were observed when upon comparison of the control and IF groups (F (1,88) = 2.626, P = 0.1087 for the treatment factor) (Fig. <xref ref-type="fig" rid="Fig2">2a</xref>). This difference was not due to a greater total body mass (F (1, 88) = 0.4222, P = 0.5175 for the treatment factor; F (1, 88) = 0.1252, P = 0.7243 for the genotype factor) (Supplementary Fig. <xref ref-type="media" rid="MOESM1">S2</xref>).<fig id="Fig2"><label>Figure 2</label><caption><p>Neuronal PTEN deletion induced macrocephaly. (<bold>a</bold>) Total brain mass, two-way ANOVA followed by Holm-Sidak’s post hoc test, <sup>*</sup>P ≤ 0.01, n = 22 (C/WT, IF/HT) and 24 (C/HT, IF/WT); (<bold>b</bold>) cortical mass, two-way ANOVA followed by Holm-Sidak’s post hoc test, <sup>*</sup>P  ≤ 0.05, n = 21 (C/WT), 22 (IF/HT) and 24 (C/HT, IF/WT).</p></caption><graphic id="d29e453" xlink:href="41598_2018_26814_Fig2_HTML"></graphic></fig></p>
<p id="Par9">The changes in brain mass resulted from an increase in cortical mass (F (1, 87) = 13.06, P = 0.0005 for the genotype factor), with control HT animals showing significantly higher values than WT mice (control and IF) (P = 0.0246 for C/WT × C/HT and for C/HT × IF/WT) (Fig. <xref ref-type="fig" rid="Fig2">2b</xref>). However, neither the cerebellum (F (1, 86) = 1.052, P = 0.3079 for the treatment factor; F (1, 86) = 0.5044, P = 0.4795 for the genotype factor) (Supplementary Fig. <xref ref-type="media" rid="MOESM1">S2</xref>) nor the hippocampus (F (1, 82) = 2.437, P = 0.1224 for the treatment factor; F (1, 82) = 0.5252, P = 0.4707 for the genotype factor) (Supplementary Fig. <xref ref-type="media" rid="MOESM1">S2</xref>) showed a difference in mass.</p>
</sec>
<sec id="Sec5">
<title>Intermittent fasting increased the open arm exploration frequency in the elevated plus maze in HT animals</title>
<p id="Par10">Analysis of the elevated plus maze test showed no significant differences between groups in locomotion as determined by the total distance travelled in the apparatus (F (1, 66) = 2.726, P = 0.1035 for the treatment factor; F (1, 66) = 2.052, P = 0.1567 for the genotype factor) (Fig. <xref ref-type="fig" rid="Fig3">3a</xref>). Interestingly, intermittent fasting in HT animals decreased the latency to first entry (P = 0.0279 for IF/WT × IF/HT) (Fig. <xref ref-type="fig" rid="Fig3">3b</xref>, Supplementary Fig. <xref ref-type="media" rid="MOESM1">S3</xref>) and increased the number of entries (P = 0.0453 for IF/WT × IF/HT) (Fig. <xref ref-type="fig" rid="Fig3">3c</xref>, Supplementary Fig. <xref ref-type="media" rid="MOESM1">S3</xref>) into the open arms. No differences were found in the frequency of exploration of the central area (Fig. <xref ref-type="fig" rid="Fig3">3d</xref>, Supplementary Fig. <xref ref-type="media" rid="MOESM1">S3</xref>) or closed arms (Fig. <xref ref-type="fig" rid="Fig3">3e</xref>, Supplementary Fig. <xref ref-type="media" rid="MOESM1">S3</xref>). Representative exploration profiles for the various groups are shown in the heat map plot in Fig. <xref ref-type="fig" rid="Fig3">3f</xref>.<fig id="Fig3"><label>Figure 3</label><caption><p>Intermittent fasting increased the exploration of open arms in HT animals in the elevated plus maze assay. (<bold>a</bold>) Total distance travelled, two-way ANOVA followed by Holm-Sidak’s post hoc test, P &gt; 0.05, n = 16 (C/HT, IF/HT), 18 (C/WT), and 20 (IF/WT); (<bold>b</bold>) latency to first entry in open arms, Kruskal-Wallis test, <sup>*</sup>P ≤ 0.05, n = 16 (C/HT, IF/HT), 18 (C/WT), and 20 (IF/WT); (<bold>c</bold>) number of entries in open arms, Kruskal-Wallis test, <sup>*</sup>P ≤ 0.05, n = 16 (C/HT, IF/HT), 18 (C/WT), and 20 (IF/WT); (<bold>d</bold>) number of entries in central area, Kruskal-Wallis test, P &gt; 0.05, n = 16 (C/HT, IF/HT), 18 (C/WT), and 20 (IF/WT); (<bold>e</bold>) number of entries in closed arms, Kruskal-Wallis test, P &gt; 0.05, n = 16 (C/HT, IF/HT), 18 (C/WT), and 20 (IF/WT); (<bold>f</bold>) representative heat map plot for animal movement in the apparatus.</p></caption><graphic id="d29e534" xlink:href="41598_2018_26814_Fig3_HTML"></graphic></fig></p>
</sec>
<sec id="Sec6">
<title>Intermittent fasting did not alter locomotion but exerted a decrease in time in central area exploration in HT animals</title>
<p id="Par11">Animals from all groups showed a decline in locomotor activity in up to 5 min (Fig. <xref ref-type="fig" rid="Fig4">4a</xref>). Because they reached a stable state after 5 min exploring the apparatus, we limited the analysis of the different behavioral parameters to this period of time. All groups showed analogous exploratory activity (F (3, 35) = 0.9707, P = 0.4175 for the group factor) (Fig. <xref ref-type="fig" rid="Fig4">4a</xref>) and statistically similar travelled distances (F (1,33) = 3.575, P = 0.0675 for the treatment factor; F (1, 33) = 0.1699, P = 0.6829 for the genotype factor) (Fig. <xref ref-type="fig" rid="Fig4">4b</xref>) and mean speeds (F (1,33) = 3.460, P = 0.0718 for the treatment factor; F (1, 33) = 0.1472, P = 0.7037 for the genotype factor) (Fig. <xref ref-type="fig" rid="Fig4">4c</xref>). Freezing response in IF groups was significantly greater than in control groups (F (1, 33) = 4.886, P = 0.0341 for the treatment factor) (Fig. <xref ref-type="fig" rid="Fig4">4d</xref>).<fig id="Fig4"><label>Figure 4</label><caption><p>Intermittent fasting induced a decrease in central area exploration in HT animals in the open field test. (<bold>a</bold>) Curve of distance travelled, two-way ANOVA followed by Holm-Sidak’s post hoc test, P &gt; 0.05, n = 8 (C/HT, IF/HT), 11 (C/WT), and 12 (IF/WT); (<bold>b</bold>) distance travelled in first 5 min, two-way ANOVA followed by Holm-Sidak’s post hoc test, P &gt; 0.05, n = 7 (C/HT), 8 (IF/HT) and 11 (C/WT, IF/WT); (<bold>c</bold>) mean speed in first 5 min, two-way ANOVA followed by Holm-Sidak’s post hoc test, P &gt; 0.05, n = 7 (C/HT), 8 (IF/HT) and 11 (C/WT, IF/WT); (<bold>d</bold>) total time of freezing behavior in first 5 min, two-way ANOVA followed by Holm-Sidak’s post hoc test, P ≤ 0.05 for the treatment factor, n = 7 (C/HT), 8 (IF/HT) and 11 (C/WT, IF/WT); (<bold>e</bold>) curves for time in central and peripheral areas; (<bold>f</bold>) time in central area in first 5 min, two-way ANOVA followed by Holm-Sidak’s post hoc test, <sup>*</sup>P ≤ 0.05, n = 7 (C/HT), 8 (IF/HT) and 11 (C/WT, IF/WT); (<bold>g</bold>) time in peripheral area in first 5 min, two-way ANOVA followed by Holm-Sidak’s post hoc test, <sup>*</sup>P ≤ 0.05, n = 7 (C/HT), 8 (IF/HT) and 11 (C/WT, IF/WT); (<bold>h</bold>) representative heat map plot for animal movement in the apparatus.</p></caption><graphic id="d29e595" xlink:href="41598_2018_26814_Fig4_HTML"></graphic></fig></p>
<p id="Par12">Regarding the exploration patterns in the open field, animals tended to primarily explore the peripheral area, with an increase in the time spent in the central area over time (Fig. <xref ref-type="fig" rid="Fig4">4e</xref>). Notably, a delay in entering the central area was seen for IF HT animals (Fig. <xref ref-type="fig" rid="Fig4">4e</xref>). Indeed, the IF HT group spent significantly less time in the central area than the control WT group (F (1, 33) = 10.33, P = 0.00029 for the treatment factor; P = 0.0149 for C/WT × IF/HT) (Fig. <xref ref-type="fig" rid="Fig4">4f</xref>) and consequently more time in the periphery (F (1, 33) = 10.33, P = 0.00029 for the treatment factor; P = 0.0154 for C/WT × IF/HT) (Fig. <xref ref-type="fig" rid="Fig4">4g</xref>). Representative exploratory patterns for the different groups are presented in the heat map plot in Fig. <xref ref-type="fig" rid="Fig4">4h</xref>.</p>
</sec>
<sec id="Sec7">
<title>Intermittent fasting did not modify spatial learning and memory</title>
<p id="Par13">Spatial memory was assessed using the Morris water maze assay. All animals showed a significant decrease in the latency to platform over time (F (4, 204) = 75.95, P ≤ 0.0001 for the time factor), but there were no significant differences in learning between groups (F (3, 51) = 1.548, P = 0.2135 for the group factor) (Fig. <xref ref-type="fig" rid="Fig5">5a</xref>).<fig id="Fig5"><label>Figure 5</label><caption><p>Neither treatment nor genotype significantly altered short-term spatial reference memory in the Morris water maze assay. (<bold>a</bold>) Learning curve of platform location, two-way ANOVA with repeated measures followed by Holm-Sidak’s post hoc test, P &gt; 0.05, n = 12 (C/HT, IF/HT), 15 (C/WT) and 16 (IF/WT); (<bold>b</bold>) total distance travelled, two-way ANOVA followed by Holm-Sidak’s post hoc test, P &gt; 0.05, n = 11 (IF/HT), 12 (C/HT), 14 (C/WT) and 16 (IF/WT); (<bold>c</bold>) mean swimming speed, two-way ANOVA followed by Holm-Sidak’s post hoc test, P &gt; 0.05, n = 11 (IF/HT), 12 (C/HT), 14 (C/WT) and 16 (IF/WT); (<bold>d</bold>) distance travelled in each quadrant of the Morris water maze, one-way ANOVA, <sup>*</sup>P ≤ 0.001, n = 12 (C/HT, IF/HT), 15 (C/WT) and 16 (IF/WT); (<bold>e</bold>) time spent in target quadrant, two-way ANOVA followed by Holm-Sidak’s post hoc test, P &gt; 0.05, n = 11 (IF/HT), 12 (C/HT), 14 (C/WT) and 16 (IF/WT); (<bold>f</bold>) mean distance from platform area, two-way ANOVA followed by Holm-Sidak’s post hoc test, P &gt; 0.05, n = 11 (IF/HT), 12 (C/HT), 14 (C/WT) and 16 (IF/WT).</p></caption><graphic id="d29e651" xlink:href="41598_2018_26814_Fig5_HTML"></graphic></fig></p>
<p id="Par14">Short-term memory was tested by probing the animals in the water maze in the absence of the platform 4 h after the last learning trial. There were no significant differences between the total distance travelled (F (1, 49) = 1.234, P = 0.2721 for the treatment factor; F (1, 49) = 0.2385, P = 0.6275 for the genotype factor) (Fig. <xref ref-type="fig" rid="Fig5">5b</xref>) or mean swimming speed (F (1, 49) = 1.043, P = 0.3122 for the treatment factor; F (1, 49) = 0.2912, P = 0.5919 for the genotype factor) (Fig. <xref ref-type="fig" rid="Fig5">5c</xref>). All groups showed a significant preference for the target quadrant (F (3, 153) = 51.14, P ≤ 0.0001 for the quadrant factor; P &lt; 0.01 for all comparisons between the target quadrant and the right, left or opposite quadrants respective to each group) (Fig. <xref ref-type="fig" rid="Fig5">5d</xref>), indicating a similar consolidation and evocation of short-term spatial memory. Indeed, there was no difference between groups in any parameter analyzed, including time in target quadrant (F (1, 49) = 0.06066, P = 0.8065 for the treatment factor; F (1, 49) = 1.587, P = 0.2138 for the genotype factor) (Fig. <xref ref-type="fig" rid="Fig5">5e</xref>), mean distance from platform (F (1, 49) = 0.2060, P = 0.6519 for the treatment factor; F (1, 49) = 2.867, P = 0.0968 for the genotype factor) (Fig. <xref ref-type="fig" rid="Fig5">5f</xref>), number of entries into the target quadrant (P &gt; 0.05 for all comparisons) (Supplementary Fig. <xref ref-type="media" rid="MOESM1">S4</xref>), or number of entries into the platform area (P &gt; 0.05 for all comparisons) (Supplementary Fig. <xref ref-type="media" rid="MOESM1">S4</xref>).</p>
<p id="Par15">Comparable profiles were observed among all groups (F (3, 30) = 2.345, P = 0.0927 for the group factor) and between probes (F (4, 120) = 1.052, P = 3835 for the time factor) in the memory extinction test (Supplementary Fig. <xref ref-type="media" rid="MOESM1">S4</xref>). With regard to spatial working memory, animals showed a decrease in the latency to the platform over consecutive trials (F (3, 87) = 21.07, P ≤ 0.0001 for the time factor), although no differences between groups were observed (F (3, 29) = 1.730, P = 0.1828 for the group factor) (Supplementary Fig. <xref ref-type="media" rid="MOESM1">S4</xref>). Similar results were obtained in the novel object recognition assay (P &gt; 0.05 for all comparisons) (Supplementary Fig. <xref ref-type="media" rid="MOESM1">S5</xref>).</p>
</sec>
<sec id="Sec8">
<title>Intermittent fasting rescued the fear-associated memory deficit displayed by HT animals in the passive avoidance test</title>
<p id="Par16">Fear-associated memory was assessed using the passive avoidance test. All groups showed a similar baseline latency to move to the dark chamber in the exposure stage (Fig. <xref ref-type="fig" rid="Fig6">6</xref>, Supplementary Fig. <xref ref-type="media" rid="MOESM1">S6</xref>). WT animals showed a significant increase in latency in the probe stage regardless of the diet regimen [control (P = 0.0057 for C/WT Exposure × Probe); IF (P ≤ 0.0001 for IF/WT Exposure × Probe)]. On the other hand, no significant change in the latency to the dark chamber was found in control HT animals (P &gt; 0.9999 for C/HT Exposure × Probe), an effect that was rescued by IF (P = 0.0013 for IF/HT Exposure × Probe).<fig id="Fig6"><label>Figure 6</label><caption><p>Intermittent fasting rescued the fear memory deficit of HT animals in the passive avoidance test. Latency to dark chamber in the exposure and probe stages, Kruskal-Wallis test, <sup>*</sup>P ≤ 0.01, n = 10 (IF/HT), 11 (C/WT), 13 (C/HT) and 15 (IF/WT).</p></caption><graphic id="d29e709" xlink:href="41598_2018_26814_Fig6_HTML"></graphic></fig></p>
</sec>
<sec id="Sec9">
<title>Expression of PTEN but not all major downstream markers was altered in HT animals</title>
<p id="Par17">Results from statistical analyses of western blotting data are grouped on Table <xref ref-type="table" rid="Tab1">1</xref>. HT animals showed significantly lower PTEN levels in the brain cortex than WT animals (Fig. <xref ref-type="fig" rid="Fig7">7a</xref>, Supplementary Fig. <xref ref-type="media" rid="MOESM1">S7</xref>), with no IF-associated changes. AKT expression was similar across groups (Fig. <xref ref-type="fig" rid="Fig7">7b</xref>, Supplementary Fig. <xref ref-type="media" rid="MOESM1">S7</xref>), but control HT animals showed significantly higher levels of p-AKT<sup>T308</sup> than control WT mice (Fig. <xref ref-type="fig" rid="Fig7">7b</xref>, Supplementary Fig. <xref ref-type="media" rid="MOESM1">S7</xref>), an effect that was absent in the IF HT group. These data indicate that a PI3K-dependent overactivation of AKT, induced by neuronal <italic>Pten</italic> haploinsufficiency, might be rescued by IF. Notably, no differences were observed in phosphorylation at the mTOR-dependent AKT phosphorylation site (p-AKT<sup>S473</sup>) (Fig. <xref ref-type="fig" rid="Fig7">7d</xref>, Supplementary Fig. <xref ref-type="media" rid="MOESM1">S7</xref>) nor in the total expression of its downstream target S6 (Fig. <xref ref-type="fig" rid="Fig7">7e</xref>, Supplementary Fig. <xref ref-type="media" rid="MOESM1">S7</xref>) or its phosphorylated form, p-S6 (Fig. <xref ref-type="fig" rid="Fig7">7f</xref>, Supplementary Fig. <xref ref-type="media" rid="MOESM1">S7</xref>)). Levels of the glutamatergic ionotropic receptors AMPA (Supplementary Figs <xref ref-type="media" rid="MOESM1">S8</xref> and <xref ref-type="media" rid="MOESM1">S9</xref>), NR1 (Supplementary Figs <xref ref-type="media" rid="MOESM1">S8</xref> and <xref ref-type="media" rid="MOESM1">S9</xref>), NR2a (Supplementary Figs <xref ref-type="media" rid="MOESM1">S8</xref> and <xref ref-type="media" rid="MOESM1">S9</xref>), and NR2b (Supplementary Figs <xref ref-type="media" rid="MOESM1">S8</xref> and <xref ref-type="media" rid="MOESM1">S9</xref>)) and the synaptic markers PSD-95 (Supplementary Figs <xref ref-type="media" rid="MOESM1">S8</xref> and <xref ref-type="media" rid="MOESM1">S9</xref>) and synaptophysin (Supplementary Figs <xref ref-type="media" rid="MOESM1">S8</xref> and <xref ref-type="media" rid="MOESM1">S9</xref>) were also unchanged. A summary of the statistical analysis of western blot data is shown in Table <xref ref-type="table" rid="Tab1">1</xref>. The loading controls (β-actin gels) are shown in Supplementary Fig. <xref ref-type="media" rid="MOESM1">S10</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Summary of western blotting statistical analyses.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Protein analyzed</th><th>ANOVA factor or Post-hoc test</th><th>Groups compared</th><th>F (DFn, DFd)</th><th>P value</th><th>Statistical significance?</th></tr></thead><tbody><tr><td rowspan="7">PTEN</td><td>Interaction</td><td>Treatment × Genotype</td><td>F (1, 32) = 0.4084</td><td>0.5273</td><td>—</td></tr><tr><td>Treatment</td><td>Control × IF</td><td>F (1, 32) = 0.7822</td><td>0.3831</td><td>—</td></tr><tr><td>Genotype</td><td>WT × HT</td><td>F (1, 32) = 6.356</td><td>0.0169</td><td>Yes</td></tr><tr><td rowspan="4">Holm-Sidak’s multiple comparisons test</td><td>C/WT × C/HT</td><td>—</td><td>0.1525</td><td>—</td></tr><tr><td>IF/WT × IF/HT</td><td>—</td><td>0.5752</td><td>—</td></tr><tr><td>C/WT × IF/WT</td><td>—</td><td>0.5877</td><td>—</td></tr><tr><td>C/HT × IF/HT</td><td>—</td><td>0.8633</td><td>—</td></tr><tr><td rowspan="3">AKT</td><td>Interaction</td><td>Treatment × Genotype</td><td>F (1, 32) = 0.07327</td><td>0.7884</td><td>—</td></tr><tr><td>Treatment</td><td>Control × IF</td><td>F (1, 32) = 0.1903</td><td>0.6656</td><td>—</td></tr><tr><td>Genotype</td><td>WT × HT</td><td>F (1, 32) = 0.4513</td><td>0.5065</td><td>—</td></tr><tr><td rowspan="7">p-AKT T308/AKT</td><td>Interaction</td><td>Treatment × Genotype</td><td>F (1, 32) = 4.027</td><td>0.0533</td><td>—</td></tr><tr><td>Treatment</td><td>Control × IF</td><td>F (1, 32) = 1.024</td><td>0.3191</td><td>—</td></tr><tr><td>Genotype</td><td>WT × HT</td><td>F (1, 32) = 4.288</td><td>0.0465</td><td>Yes</td></tr><tr><td rowspan="4">Holm-Sidak’s multiple comparisons test</td><td>C/WT × C/HT</td><td>—</td><td>0.0412</td><td>Yes</td></tr><tr><td>IF/WT × IF/HT</td><td>—</td><td>0.9642</td><td>—</td></tr><tr><td>C/WT × IF/WT</td><td>—</td><td>0.8422</td><td>—</td></tr><tr><td>C/HT × IF/HT</td><td>—</td><td>0.1707</td><td>—</td></tr><tr><td rowspan="3">p-AKT S473/AKT</td><td>Interaction</td><td>Treatment × Genotype</td><td>F (1, 32) = 0.07327</td><td>0.7884</td><td>—</td></tr><tr><td>Treatment</td><td>Control × IF</td><td>F (1, 32) = 0.1903</td><td>0.6656</td><td>—</td></tr><tr><td>Genotype</td><td>WT × HT</td><td>F (1, 32) = 0.4513</td><td>0.5065</td><td>—</td></tr><tr><td rowspan="3">S6</td><td>Interaction</td><td>Treatment × Genotype</td><td>F (1, 32) = 0.02098</td><td>0.8857</td><td>—</td></tr><tr><td>Treatment</td><td>Control × IF</td><td>F (1, 32) = 0.4574</td><td>0.5037</td><td>—</td></tr><tr><td>Genotype</td><td>WT × HT</td><td>F (1, 32) = 1.428</td><td>0.2409</td><td>—</td></tr><tr><td rowspan="3">p-S6/S6</td><td>Interaction</td><td>Treatment × Genotype</td><td>F (1, 32) = 0.9075</td><td>0.3479</td><td>—</td></tr><tr><td>Treatment</td><td>Control × IF</td><td>F (1, 32) = 0.7840</td><td>0.3825</td><td>—</td></tr><tr><td>Genotype</td><td>WT × HT</td><td>F (1, 32) = 1.366</td><td>0.2512</td><td>—</td></tr><tr><td rowspan="3">AMPA</td><td>Interaction</td><td>Treatment × Genotype</td><td>F (1, 32) = 1.087</td><td>0.3050</td><td>—</td></tr><tr><td>Treatment</td><td>Control × IF</td><td>F (1, 32) = 0.2580</td><td>0.6150</td><td>—</td></tr><tr><td>Genotype</td><td>WT × HT</td><td>F (1, 32) = 0.7687</td><td>0.3872</td><td>—</td></tr><tr><td rowspan="3">NR1</td><td>Interaction</td><td>Treatment × Genotype</td><td>F (1, 32) = 0.8696</td><td>0.3580</td><td>—</td></tr><tr><td>Treatment</td><td>Control × IF</td><td>F (1, 32) = 1.877</td><td>0.1803</td><td>—</td></tr><tr><td>Genotype</td><td>WT × HT</td><td>F (1, 32) = 1.871</td><td>0.1809</td><td>—</td></tr><tr><td rowspan="3">NR2a</td><td>Interaction</td><td>Treatment × Genotype</td><td>F (1, 31) = 1. 367</td><td>0.2513</td><td>—</td></tr><tr><td>Treatment</td><td>Control × IF</td><td>F (1, 31) = 0.03016</td><td>0.8633</td><td>—</td></tr><tr><td>Genotype</td><td>WT × HT</td><td>F (1, 31) = 1.380</td><td>0.249</td><td>—</td></tr><tr><td rowspan="3">NR2b</td><td>Interaction</td><td>Treatment × Genotype</td><td>F (1,24) = 0.9843</td><td>0.3310</td><td>—</td></tr><tr><td>Treatment</td><td>Control × IF</td><td>F (1,24) = 0.2853</td><td>0.5981</td><td>—</td></tr><tr><td>Genotype</td><td>WT × HT</td><td>F (1,24) = 1.885</td><td>0.1825</td><td>—</td></tr><tr><td rowspan="3">PSD-95</td><td>Interaction</td><td>Treatment × Genotype</td><td>F (1, 32) = 1.896</td><td>0.1781</td><td>—</td></tr><tr><td>Treatment</td><td>Control × IF</td><td>F (1, 32) = 0.7113</td><td>0.4053</td><td>—</td></tr><tr><td>Genotype</td><td>WT × HT</td><td>F (1,32) = 1.054</td><td>0.3123</td><td>—</td></tr><tr><td rowspan="3">Synaptophysin</td><td>Interaction</td><td>Treatment × Genotype</td><td>F (1, 31) = 0.5522</td><td>0.4630</td><td>—</td></tr><tr><td>Treatment</td><td>Control × IF</td><td>F (1, 31) = 1.313</td><td>0.2606</td><td>—</td></tr><tr><td>Genotype</td><td>WT × HT</td><td>F (1, 31) = 0.08962</td><td>0.7667</td><td>—</td></tr></tbody></table></table-wrap><fig id="Fig7"><label>Figure 7</label><caption><p>PTEN/AKT signaling pathway. Protein levels assessed through western blotting. (<bold>a</bold>) PTEN; (<bold>b</bold>) total AKT; (<bold>c</bold>) p-AKT<sup>T308</sup> normalized by total AKT; (<bold>d</bold>) p-AKT<sup>S473</sup> normalized by total AKT; (<bold>e</bold>) total S6; (<bold>f</bold>) p-S6 normalized by total S6; (<bold>g</bold>) representative bands. Two-way ANOVA followed by Holm-Sidak’s post hoc test, <sup>*</sup>F (1,32) = 6.356, P = 0.0169 for the genotype factor in the two-way ANOVA test in (<bold>a</bold>). <sup>*</sup>P  ≤ 0.05 for C/WT × C/HT in (<bold>c</bold>), n = 9 in all groups. Full length blots are provided in the Supplementary Figs <xref ref-type="media" rid="MOESM1">S8</xref> and <xref ref-type="media" rid="MOESM1">S10</xref>.</p></caption><graphic id="d29e1625" xlink:href="41598_2018_26814_Fig7_HTML"></graphic></fig></p>
</sec>
</sec>
<sec id="Sec10" sec-type="discussion">
<title>Discussion</title>
<p id="Par18">We chose intermittent fasting as a tool to study the effects of <italic>Pten</italic> haploinsufficiency on the CNS as it is an environmental intervention that is known to influence many relevant pathways that modulate CNS structure and function and thus has the potential to stimulate mutant animals and possibly rescue the expected phenotypic deficits. In our study, IF did not influence the gain in body mass over time, even though the IF groups presented intermittent body mass loss on fasting days (Fig. <xref ref-type="fig" rid="Fig1">1a</xref>). Despite the significantly lower average food consumption (Fig. <xref ref-type="fig" rid="Fig1">1b</xref>), the absolute food consumption of the IF animals was biologically very similar to that of the control mice, considering that the IF animals were under conditions of complete fasting for half of the time. This similarity indicates that, on <italic>ad libitum</italic> food days, animals from the IF groups consumed almost twice as much food as control mice, an effect that could explain the counterbalance in the body mass after refeeding. Indeed, Anson <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR31">31</xref></sup> also observed that mice under IF conditions consumed similar amounts of food as control animals, thus preserving body mass<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. However, food consumption and body mass control profiles are markedly variable in the literature, a variation that could have its origin in many factors, such as genetic background, housing conditions, energy source and palatability of the diet offered<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>.</p>
<p id="Par19">Macrocephaly is remarkably prevalent in a subset of autism spectrum disorders<sup><xref ref-type="bibr" rid="CR33">33</xref></sup> that is frequently associated with <italic>Pten</italic> mutations<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. Previous studies of <italic>Pten</italic> knockout models have shown that these animals present a macrocephalic phenotype<sup><xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR34">34</xref></sup>. We observed that HT mice were macrocephalic (Fig. <xref ref-type="fig" rid="Fig2">2a</xref>), particularly due to an increase in cortical mass (Fig. <xref ref-type="fig" rid="Fig2">2c</xref>). However, intermittent fasting did not alter the brain nor cortical mass, thus, not implicating IF in gross anatomical alterations.</p>
<p id="Par20">Contrary to that previously reported by others<sup><xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR34">34</xref></sup>, we found no alterations in hippocampal or cerebellar mass in <italic>Pten</italic> neuronal haploinsufficient mice (Supplementary Fig. <xref ref-type="media" rid="MOESM1">S2</xref>). This contrast could be derived from methodological particularities, since variabilities in PTEN studies in the literature have already been associated with differences in the genetic background of mouse models<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. Kwon <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR18">18</xref></sup> and Backman <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>, for instance, studied homozygous <italic>Pten</italic> deletion by using <italic>Cre</italic> expression directed by the <italic>Gfap</italic> (glial fibrillary acidic protein) promoter. Kwon <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> and Napoli <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>, alternatively, used a model similar to that used in our study (<italic>Nse-Cre</italic>), assessing homozygous and heterozygous <italic>Pten</italic> deletion, respectively. In addition, the age of the animals used for these analyses also varied (from 2 through 29 weeks of age), adding another important variable.</p>
<p id="Par21">Many groups observed an increase in locomotor activity of animals with neuronal <italic>Pten</italic> deletion<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR36">36</xref>,<xref ref-type="bibr" rid="CR37">37</xref></sup>, although the animals might have avoided the central area of the open field<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR38">38</xref></sup>. In our study, even though we observed no differences in mobility (Fig. <xref ref-type="fig" rid="Fig4">4a,b,c</xref>), we found that neuronal <italic>Pten</italic> deletion decreased central area exploration when animals were under IF conditions, a result that could be individually interpreted as an anxiogenic effect. Interestingly, HT animals exhibited a greater exploratory profile in the elevated plus maze assay than WT animals (Fig. <xref ref-type="fig" rid="Fig3">3</xref>), a behavior that has also been observed by others<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR26">26</xref></sup>, although Smith <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR36">36</xref></sup> did not corroborate it, even in response to a stressful stimulus<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. This effect, in contrast, is usually interpreted as an anxiolytic indicator. Therefore, these data from the elevated plus maze and open field assays, although supposedly paradoxical, seem to be corroborated by other studies.</p>
<p id="Par22">The apparently controversial observed anxiety behavior assessed through these tests is not an uncommon event, and supposed inconsistencies have already been published and discussed previously<sup><xref ref-type="bibr" rid="CR39">39</xref>,<xref ref-type="bibr" rid="CR40">40</xref></sup>. This circumstance could have been due to the influence of the circadian rhythm or daily variations in the state of animal behavior at the moment of assessment, in addition to the effect of many particularities and factors of anxiety behavior that are differently observed by each behavioral assay<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. Therefore, these disparities not only do not invalidate the results but actually highlight the importance of a further dissection of the anxiety-associated characteristics in this context, including the assessment of impulsivity and risk-taking behaviors.</p>
<p id="Par23">Discrepant results have been reported regarding spatial memory in <italic>Pten</italic> knockout mice. A memory deficit in the Morris water maze was originally described by Kwon <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> in homozygous <italic>Nse-Cre</italic>-driven <italic>Pten</italic>-deleted animals<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. However, in <italic>GFAP-Cre Pten</italic>-deleted HT mice, Smith <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR36">36</xref></sup> did not observe any learning or memory changes, even in kainate-challenged animals<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. In our study, all animals effectively learned the platform’s position (Fig. <xref ref-type="fig" rid="Fig5">5a</xref>) and similarly retained the memory of the target quadrant for up to 4 consecutive days post-training, suggesting similar learning and extinction patterns between the different genotypes as well as the different feeding regimens (Supplementary Fig. <xref ref-type="media" rid="MOESM1">S4</xref>).</p>
<p id="Par24">Thus, with this water maze protocol, animals did not show significant spatial memory extinction, an indication that the assay parameters, <italic>e</italic>.<italic>g</italic>., number of training trials and time interval between probes, although satisfactorily induced learning of a spatial memory paradigm (<italic>i</italic>.<italic>e</italic>., platform localization in a water maze based on environmental spatial cues), might have been too strong to dissociate possible – if any – spatial memory effects induced by neuronal <italic>Pten</italic> haploinsufficiency. Additionally, we were unable to observe any effect of <italic>Pten</italic> conditional deletion on recognition memory (Supplementary Fig. <xref ref-type="media" rid="MOESM1">S5</xref>), reinforcing the notion that specific parameters and/or conditions might be required to better elucidate the occurrence of cognitive deficits induced by a partial or total absence of neuronal PTEN. Other studies observed a deficit in social recognition memory<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR34">34</xref></sup>, indicating that these mice might indeed have an impairment in this memory type, although whether this effect is exclusive to social behavior or if it could be generalized to inanimate object recognition is unclear.</p>
<p id="Par25">Similarly, there is also no consensus on the effect of PTEN deletion on fear memory. While mice with neuronal PTEN deletion directed by the GFAP promoter on a <italic>status epilepticus</italic> protocol showed increased learning in the fear conditioning test<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>, the original description of homozygous deletion through <italic>Nse-Cre</italic> mice by Kwon <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> did not show fear conditioning alterations<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. In our study, however, HT mice exhibited an impairment in the passive avoidance test (Fig. <xref ref-type="fig" rid="Fig6">6</xref>), suggesting that strong aversive stimuli such as those that are fear-dependent are required to detect subtle behavioral anomalies induced by neuronal <italic>Pten</italic> haploinsufficiency. Although these behavioral tests – passive avoidance and fear conditioning – assess different types of fear memory, the complex circuitry that supports fear-associated processes appears to have a common mechanism of learned fear encoding<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>.</p>
<p id="Par26">Interestingly, this fear-dependent memory impairment was effectively reversed by IF, emphasizing the modulatory potential of such environmental interventions in modulating the behavioral profile in this model. Notably, anxiety behavior is closely associated with learning and memory processes<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. Therefore, we cannot rule out the possibility of an overlap between the anxiolytic/anxiogenic effect induced by neuronal PTEN haploinsufficiency under IF conditions and the observed fear memory outcome. Still, the basal latency to enter the dark zone was similar in all groups (Fig. <xref ref-type="fig" rid="Fig6">6</xref>), strengthening the hypothesis of a deficit in passive avoidance behavior in HT mice.</p>
<p id="Par27">The western blots results confirmed reduced PTEN expression in the cortex (Fig. <xref ref-type="fig" rid="Fig7">7a</xref>) and increased AKT activation (p-AKT<sup>T308</sup>, Fig. <xref ref-type="fig" rid="Fig7">7b</xref>) in HT animals compared to those in WT animals. This effect was also confirmed in primary cortical neurons cultivated from WT and HT embryos (Supplementary Figs <xref ref-type="media" rid="MOESM1">S11</xref> and <xref ref-type="media" rid="MOESM1">S12</xref>), which, together with the macrocephaly data (Fig. <xref ref-type="fig" rid="Fig2">2b</xref>), strengthen the validation of the model in our laboratory. However, we found no significant differences in p-AKT<sup>S473</sup> or p-S6 levels, which are indicative of the activation state of the AKT signaling pathway. In addition, similarly to Smith <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>, we found no differences in the levels of synaptic markers (PSD-95, synaptophysin) or glutamatergic receptors (AMPA, NR1, NR2a, NR2b), limiting the initial assessment of the molecular effects causing the observed behavioral phenotype. Considering that, in this model, the <italic>Pten</italic> heterozygous deletion is selective for mature neurons, normal PTEN levels and, consequently, unaffected downstream signaling in other cell types might mitigate the sensitivity of the western blotting assay. Therefore, future studies using this model should consider assessing molecular signaling effects through alternative approaches (<italic>e</italic>.<italic>g</italic>., immunofluorescence of brain tissues).</p>
<p id="Par28">Borderline and paradoxical cognitive effects have frequently been observed in neuronal <italic>Pten</italic> haploinsufficiency and complete conditional knockout models. These borderline effects could stem from allostatic adaptations of affected signaling pathways and behaviors in these animals, highlighting that an external stimulation might be necessary to reveal defective phenotypes. Our findings support the modulatory role of neuronal PTEN in anxiety, learning and memory. We found that, in HT mice, IF uncovers both anxiolytic (elevated plus maze) and anxiogenic (open field) behaviors in parallel. Although no effect on spatial memory was observed, HT animals presented an impairment in fear memory – a phenotype interestingly rescued by IF, an environmental intervention, without differential effects on food consumption or brain mass. Considering our findings, we advise caution regarding the assumption of expected phenotypes of mutant animals. Further studies could benefit from environmental interventions or other stimuli to uncover hidden phenotype effects, thus allowing for a clearer and more comprehensive evaluation of the molecular mechanisms derived from <italic>Pten</italic> haploinsufficiency in neurons.</p>
</sec>
<sec id="Sec11" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="Sec12">
<title>Animals and Intermittent Fasting</title>
<p id="Par29">The <italic>Pten</italic><sup><italic>loxP/</italic>+</sup>; <italic>Nse-Cre</italic><sup>+</sup> lineage was originated by crossing <italic>Pten</italic><sup><italic>loxP/loxP</italic></sup> (donated by Dr. Antonio Di Cristofano from Albert Einstein College of Medicine, Bronx, NY, USA) and <italic>Nse-Cre</italic><sup>+</sup> mice (B6.Cg-Tg(Eno2-cre)39Jme/J, from Jackson Laboratory, Bay Harbor, ME, USA), within a C57Bl/6J background. Mice from the <italic>Pten</italic><sup><italic>loxP/</italic>+</sup>; <italic>Nse-Cre</italic><sup>+</sup> lineage were maintained in microisolator plastic cages in groups of up to 5 animals at 22 ± 2 °C in a 12-h light/dark cycle at the animal facility of the Laboratory of Molecular Neuropharmacology (Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil). All experimental procedures were approved by and performed under the regulation of the Ethical Committee for Animal Research of the Institute of Biomedical Sciences (CEUA/ICB/USP, protocol #167, book 2, p. 167) and were in accordance with the guidelines of the <italic>Sociedade Brasileira de Ciência em Animais de Laboratório</italic> (SBCAL). In this study, animals of <italic>Pten</italic><sup>+<italic>/</italic>+</sup>; <italic>Nse-Cre</italic><sup>+</sup>, <italic>Pten</italic><sup><italic>loxP/</italic>+</sup>; <italic>Nse-Cre</italic><sup><italic>−</italic></sup>, or <italic>Pten</italic><sup><italic>loxP/loxP</italic></sup>; <italic>Nse-Cre</italic><sup><italic>−</italic></sup> genotypes were included in the wild-type (WT) group, as their <italic>Pten</italic> genes were not passive of Cre recombination. The neuronal PTEN heterozygous deletion (HT) group was consisted of <italic>Pten</italic><sup><italic>loxP/</italic>+</sup>; <italic>Nse-Cre</italic><sup>+</sup> mice (Supplementary Fig. <xref ref-type="media" rid="MOESM1">S13</xref>). Considering the remarkable greater incidence of autism spectrum disorders in males<sup><xref ref-type="bibr" rid="CR44">44</xref></sup> and the sex-specific differences in stereotypical behavior of <italic>Pten</italic> haploinsufficient mice<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>, we chose to assess the effect of intermittent fasting (IF) and neuronal <italic>Pten</italic> haploinsufficiency on male mice.</p>
<p id="Par30">The intermittent fasting (IF) protocol<sup><xref ref-type="bibr" rid="CR46">46</xref></sup> consisted of a daily alternation of <italic>ad libitum</italic> food followed by a day of complete fasting. Food was removed/replaced every day at 5:00 pm. The IF regimen was started when animals were 3–4 months old and was maintained for approximately 60 days, through the behavioral assays and up until euthanasia. Body mass and food consumption were assessed during this period. Animals were euthanatized by isoflurane overdose, and their brains were rapidly dissected, evaluated for wet mass (total brain, cortex, hippocampus, and cerebellum), and stored at −80 °C.</p>
</sec>
<sec id="Sec13">
<title>Behavioral Tests</title>
<p id="Par31">Behavioral analyses started 4 weeks after the beginning of IF and were conducted from the least to most stressful test (<italic>i</italic>.<italic>e</italic>., elevated plus maze, open field, novel object recognition, Morris water maze, and passive avoidance assays). All assays were recorded and analyzed with the ANY-maze Video Tracking Software (Stoelting Co., Wood Dale, IL, USA).</p>
<sec id="Sec14">
<title>Elevated Plus Maze</title>
<p id="Par32">Elevated plus maze was used to assess fear- and anxiety-associated behavior, based on Texel <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR47">47</xref></sup> with modifications. The apparatus consisted of a cross-shaped wooden maze (with 25 × 5-cm arms) elevated by a 60-cm support. Two opposite arms were surrounded by a 20-cm wall, while the other two were open (only with a 1-cm contention step). Mice were individually placed in the central area of the apparatus, facing one of the closed arms, and their mobility within the maze was assessed over 5 min. The exploration profile within the different areas of the maze (open arms, closed arms and center) was analyzed, and anxiety behavior was assessed by examination of the open arm exploration. Animals that fell from the apparatus had to be censored from the analyses. To avoid effects of acute fasting on fear and anxiety behaviors, the test was always conducted when IF animals were fed.</p>
</sec>
<sec id="Sec15">
<title>Open Field Test</title>
<p id="Par33">The open field test was used to analyze fear- and anxiety-associated behavior, as well as exploratory behavior. The protocol was based on Kawamoto <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. Briefly, animals were allowed to freely explore for 10 min in a 40 × 40 × 15-cm plastic cage virtually divided into a central and peripheral area. Mobility was determined by distance travelled and mean speed. Anxiety-associated parameters were related to the central area exploratory profile. Cases when animals jumped out of the apparatus were censored from the analyses. Similar to the elevated plus maze, tests were conducted on days when IF animals were fed.</p>
</sec>
<sec id="Sec16">
<title>Morris Water Maze</title>
<p id="Par34">The Morris water maze protocol was based on Shaw <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR49">49</xref></sup> and Okun <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. A circular pool was filled with water (27 ± 2 °C) rendered opaque by the addition of nontoxic white paint. A circular platform (9 cm of diameter) was submerged 1 cm below the water level in one of the pool quadrants. Environmental cues were placed in the surrounding room walls to facilitate spatial localization. Refractory animals – identified by stereotypical behaviors such as thigmotaxis and/or passive buoyancy – were censored from analyses. To avoid effects of acute fasting on learning and memory, the experimental design was planned to ensure that IF animals were fed on the longest test day (<italic>i</italic>.<italic>e</italic>., the last learning trial and 4-h probe day). Consequently, all other analyses had matched and balanced fast/fed days. <italic>Learning period</italic>: Animals were trained to find the platform location through four 60-s trials for 5 consecutive days. If an animal failed to locate the platform, it was gently directed toward it and allowed to rest on it for 10 s. Latency to find the platform, averaged by trial day, was analyzed and used as an indicator of spatial learning. <italic>Spatial reference memory and memory extinction</italic>: Animals were reintroduced to the water maze in absence of the platform 4 h, 24 h, 48 h, 72 h, and 96 h after the last training trial for 60 s. Persistent swimming within the area where the platform was placed during learning was used as a measure of spatial reference memory and extinction. <italic>Spatial working memory</italic>: The animals were prompt to learn and remember a different platform position over 4 testing days. The ability to match-to-place the new platform locations between the 4 intraday trials was used as an indicator of working memory. Latency to find the platform was averaged by trial across the different days.</p>
</sec>
</sec>
<sec id="Sec17">
<title>Passive Avoidance</title>
<p id="Par35">The passive avoidance test was used to assess fear-associated learning and memory, based on the protocol from Vasconcelos <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>. The apparatus consisted of a cage with two chambers, one dark and one bright, separated by an automated door and a stainless-steel grid floor with controlled electrification. During the exposure stage, mice were individually placed in the bright chamber and received an electric foot shock of 0.5 mA for 3 s after entering the dark chamber. After 24 h, mice were reintroduced to the bright chamber of the apparatus, and the latency to move to the dark chamber was used as a measure of fear-motivated short-term memory. Animals that were refractory to this test – i.e., mice that did not move to the dark chamber in the exposure stage – were censored from the analyses. The exposure stage was always conducted on a day when IF animals were fed so that learning of the shock context was not affected by acute fasting effects.</p>
</sec>
<sec id="Sec18">
<title>Tissue Protein Extraction</title>
<p id="Par36">Cortical cytosolic protein extraction was conducted using a protocol adapted from Vasconcelos <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>. Briefly, tissues were homogenized in a glass-glass Dounce homogenizer in ice-cold lysis buffer (20 mM HEPES, 1.0 mM MgCl<sub>2</sub>, 0.5 mM EDTA, 1% NP-40, 1.0 mM EGTA, 0.5 mM PMSF, 2 g/mL leupeptin, 2 g/mL antipain, 3 mM Na<sub>3</sub>VO<sub>4</sub>, 20 mM sodium pyrophosphate) and centrifuged at 17,000 × g for 5 min at 4 °C. The supernatant was collected and stored at −80 °C for western blot analyses. Protein concentration was determined using the Bradford colorimetric method (#500-0006, Bio-Rad, Hercules, CA, USA)<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>.</p>
</sec>
<sec id="Sec19">
<title>Western Blotting</title>
<p id="Par37">Protein extracts were adjusted to a final concentration of 2.5 μg/μL in sample buffer (125 mM Tris-HCl, 4% SDS, 20% glycerol, 200 mM DTT, 0.02% bromophenol blue, pH 6.8) and subjected to SDS-PAGE electrophoresis as described by Laemmli<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>. Briefly, samples (25 μg) were separated using 10% polyacrylamide gels, transferred onto nitrocellulose membranes, blocked with 5% BSA, and incubated with primary antibodies against the following targets: PTEN (54 kDa, 1:1000, #9559 Cell Signaling Technology, Danvers, MA, USA), AKT (55 kDa, 1:2000, #sc-1619 Santa Cruz Biotechnology, Dallas, TX, USA), p-AKT<sup>T308</sup> (60 kDa, 1:750, #4056 Cell Signaling), p-AKT<sup>S473</sup> (60 kDa, 1:750, #550747 BD Biosciences, San Jose, CA, USA), S6 (32 kDa, 1:1000, #2217 Cell Signaling), p-S6 (32 kDa, 1:1000, #5364 Cell Signaling), AMPA (100 kDa, 1:500, #13185 Cell Signaling), NR1 (116 kDa, 1:500, #G8913 Sigma-Aldrich, Saint Louis, MO, USA), NR2a (180 kDa, 1:1000, #4205 Cell Signaling), NR2b (190 kDa, 1:1000, #4207 Cell Signaling), PSD-95 (95 kDa, 1:750, #sc-71933 Santa Cruz), synaptophysin (38 kDa, 1:2000, #4329 Cell Signaling), and β-Actin (42 kDa, 1:10000, #A5441 Sigma-Aldrich). Primary antibodies were diluted in 1% BSA, while secondary antibodies were diluted in 5% BSA (1:2000).</p>
</sec>
<sec id="Sec20">
<title>Statistical Analyses</title>
<p id="Par38">Results are expressed as the mean and standard deviation in graphs with bars or curves (parametric analyses) or as the median and quartiles in graphs with boxplots (non-parametric analyses). Except for curve data, the results are also represented as dot plots. Normality was assessed through the D’Agostino &amp; Pearson omnibus normality test, and, for parametric analyses, outliers were detected and removed through the ROUT method (Q = 1%). Parametric analyses were conducted through single-measure or repeated-measures, when pertinent, two-way ANOVA followed by Holm-Sidak post hoc test. Non-parametric analyses were conducted through Kruskal-Wallis test followed by Dunn’s post hoc test. All statistical analyses were performed using GraphPad Prism version 6.01 for Windows (GraphPad Software, La Jolla, CA, USA). To facilitate comparison descriptions, groups were indicated as C/WT (control, WT), C/HT (control, HT), IF/WT (intermittent fasting, WT), or IF/HT (intermittent fasting, HT) in statistical results description and in the legends.</p>
</sec>
<sec id="Sec21">
<title>Data Availability</title>
<p id="Par39">All data generated or analyzed during this study are included in this published article and its Supplementary Information file.</p>
</sec>
</sec>
<sec sec-type="supplementary-material">
<title>Electronic supplementary material</title>
<sec id="Sec22">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41598_2018_26814_MOESM1_ESM.pdf"><caption><p>Supplementary material</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p>
<bold>Electronic supplementary material</bold>
</p>
<p><bold>Supplementary information</bold> accompanies this paper at 10.1038/s41598-018-26814-6.</p>
</fn>
<fn>
<p><bold>Publisher's note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>We would like to thank Larissa de Sá Lima for the excellent technical support, Fernando de Sousa Lula for the assistance with animal care, Amanda Midori Matumoto for the remarks on behavioral analysis, and Dr. Rosana Camarini for critical reviewing the behavioral section of the manuscript. This study was financially supported by the <italic>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior</italic> (CAPES), <italic>São Paulo Research Foundation</italic> (<italic>Fundação de Amparo à Pesquisa do Estado de São Paulo</italic>, FAPESP, grants #2011/21308-8, #2013/20594-2, #2014/18689-8, #2015/25491-2, #2016/22996-9) and the NIH Intramural Research Program, National Institute on Aging. We would also like to acknowledge Nature Research Editing Service for the English language editing.</p>
</ack>
<notes notes-type="author-contribution">
<title>Author Contributions</title>
<p>J.V.C.-C., D.Z.A., N.P.M., and E.M.K. performed the experiments; J.V.C.-C. and E.M.K. analyzed the data and wrote the manuscript. All authors (J.V.C.-C., D.Z.A., N.P.M., C.S., S.C., and E.M.K.) contributed to the study design, discussed experimental results and reviewed the manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar1">
<title>Competing Interests</title>
<p id="Par40">The authors declare no competing interests.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate</article-title>
<source/>Cancer. Science (80-.).
          <year>1997</year>
<volume>275</volume>
<fpage>1943</fpage>
<lpage>1947</lpage>
<pub-id pub-id-type="doi">10.1126/science.275.5308.1943</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steck</surname>
<given-names>PA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23</article-title>
<source/>3 that is mutated in multiple advanced cancers. Nat. Genet.
          <year>1997</year>
<volume>15</volume>
<fpage>356</fpage>
<lpage>362</lpage>
<pub-id pub-id-type="pmid">9090379</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ali</surname>
<given-names>IU</given-names>
</name>
<name>
<surname>Schriml</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Dean</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity</article-title>
<source/>J. Natl. Cancer Inst.
          <year>1999</year>
<volume>91</volume>
<fpage>1922</fpage>
<lpage>1932</lpage>
<pub-id pub-id-type="doi">10.1093/jnci/91.22.1922</pub-id>
<pub-id pub-id-type="pmid">10564676</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gray</surname>
<given-names>IC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN</article-title>
<source/>Br. J. Cancer
          <year>1998</year>
<volume>78</volume>
<fpage>1296</fpage>
<lpage>1300</lpage>
<pub-id pub-id-type="doi">10.1038/bjc.1998.674</pub-id>
<pub-id pub-id-type="pmid">9823969</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cairns</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Frequent inactivation of PTEN/MMAC1 in primary prostate cancer</article-title>
<source/>Cancer Res.
          <year>1997</year>
<volume>57</volume>
<fpage>4997</fpage>
<lpage>5000</lpage>
<pub-id pub-id-type="pmid">9371490</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hemmings</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Restuccia</surname>
<given-names>DF</given-names>
</name>
</person-group>
<article-title>PI3K-PKB/Akt Pathway</article-title>
<source/>Cold Spring Harb. Perspect. Biol.
          <year>2012</year>
<volume>4</volume>
<fpage>a011189</fpage>
<lpage>a011189</lpage>
<pub-id pub-id-type="doi">10.1101/cshperspect.a011189</pub-id>
<pub-id pub-id-type="pmid">22952397</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maehama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Dixon</surname>
<given-names>JE</given-names>
</name>
</person-group>
<article-title>The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate</article-title>
<source/>J. Biol. Chem.
          <year>1998</year>
<volume>273</volume>
<fpage>13375</fpage>
<lpage>13378</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.273.22.13375</pub-id>
<pub-id pub-id-type="pmid">9593664</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Cristofano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pesce</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Cordon-Cardo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pandolfi</surname>
<given-names>PP</given-names>
</name>
</person-group>
<article-title>Pten is essential for embryonic development and tumour suppression</article-title>
<source/>Nat. Genet.
          <year>1998</year>
<volume>19</volume>
<fpage>348</fpage>
<lpage>355</lpage>
<pub-id pub-id-type="doi">10.1038/1235</pub-id>
<pub-id pub-id-type="pmid">9697695</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Podsypanina</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>1999</year>
<volume>96</volume>
<fpage>1563</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.96.4.1563</pub-id>
<pub-id pub-id-type="pmid">9990064</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice</article-title>
<source/>Curr. Biol.
          <year>1998</year>
<volume>8</volume>
<fpage>1169</fpage>
<lpage>1178</lpage>
<pub-id pub-id-type="doi">10.1016/S0960-9822(07)00488-5</pub-id>
<pub-id pub-id-type="pmid">9799734</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stambolic</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN</article-title>
<source/>Cell
          <year>1998</year>
<volume>95</volume>
<fpage>29</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(00)81780-8</pub-id>
<pub-id pub-id-type="pmid">9778245</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salmena</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Carracedo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pandolfi</surname>
<given-names>PP</given-names>
</name>
</person-group>
<article-title>Tenets of PTEN Tumor Suppression</article-title>
<source/>Cell
          <year>2008</year>
<volume>133</volume>
<fpage>403</fpage>
<lpage>414</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2008.04.013</pub-id>
<pub-id pub-id-type="pmid">18455982</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>MS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner</article-title>
<source/>Cell
          <year>2011</year>
<volume>144</volume>
<fpage>187</fpage>
<lpage>199</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2010.12.020</pub-id>
<pub-id pub-id-type="pmid">21241890</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perandones</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Correlation between synaptogenesis and the PTEN phosphatase expression in dendrites during postnatal brain development</article-title>
<source/>Mol. Brain Res.
          <year>2004</year>
<volume>128</volume>
<fpage>8</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="doi">10.1016/j.molbrainres.2004.05.021</pub-id>
<pub-id pub-id-type="pmid">15337313</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lachyankar</surname>
<given-names>MB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A role for nuclear PTEN in neuronal differentiation</article-title>
<source/>J. Neurosci.
          <year>2000</year>
<volume>20</volume>
<fpage>1404</fpage>
<lpage>1413</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-04-01404.2000</pub-id>
<pub-id pub-id-type="pmid">10662831</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Backman</surname>
<given-names>SA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease</article-title>
<source/>Nat. Genet.
          <year>2001</year>
<volume>29</volume>
<fpage>396</fpage>
<lpage>403</lpage>
<pub-id pub-id-type="doi">10.1038/ng782</pub-id>
<pub-id pub-id-type="pmid">11726926</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Groszer</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene <italic>in vivo</italic></article-title>
<source/>Science (80-.).
          <year>2001</year>
<volume>294</volume>
<fpage>2186</fpage>
<lpage>2189</lpage>
<pub-id pub-id-type="doi">10.1126/science.1065518</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwon</surname>
<given-names>CH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease</article-title>
<source/>Nat. Genet.
          <year>2001</year>
<volume>29</volume>
<fpage>404</fpage>
<lpage>411</lpage>
<pub-id pub-id-type="doi">10.1038/ng781</pub-id>
<pub-id pub-id-type="pmid">11726927</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marino</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum</article-title>
<source/>Development
          <year>2002</year>
<volume>129</volume>
<fpage>3513</fpage>
<lpage>3522</lpage>
<pub-id pub-id-type="pmid">12091320</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwon</surname>
<given-names>CH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pten Regulates Neuronal Arborization and Social Interaction in Mice</article-title>
<source/>Neuron
          <year>2006</year>
<volume>50</volume>
<fpage>377</fpage>
<lpage>388</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2006.03.023</pub-id>
<pub-id pub-id-type="pmid">16675393</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fraser</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Bayazitov</surname>
<given-names>IT</given-names>
</name>
<name>
<surname>Zakharenko</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>SJ</given-names>
</name>
</person-group>
<article-title>Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities</article-title>
<source/>Neuroscience
          <year>2008</year>
<volume>151</volume>
<fpage>476</fpage>
<lpage>488</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2007.10.048</pub-id>
<pub-id pub-id-type="pmid">18082964</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jaworski</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Spangler</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Seeburg</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Hoogenraad</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Control of dendritic arborization by the phosphoinositide-3′-kinase-Akt-mammalian target of rapamycin pathway</article-title>
<source/>J. Neurosci.
          <year>2005</year>
<volume>25</volume>
<fpage>11300</fpage>
<lpage>11312</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2270-05.2005</pub-id>
<pub-id pub-id-type="pmid">16339025</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sperow</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Phosphatase and tensin homologue (PTEN) regulates synaptic plasticity independently of its effect on neuronal morphology and migration</article-title>
<source/>J. Physiol.
          <year>2012</year>
<volume>590</volume>
<fpage>777</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.1113/jphysiol.2011.220236</pub-id>
<pub-id pub-id-type="pmid">22147265</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mattson</surname>
<given-names>MP</given-names>
</name>
</person-group>
<article-title>The PTEN phosphatase is essential for long-term depression of hippocampal synapses</article-title>
<source/>Neuromolecular Med.
          <year>2006</year>
<volume>8</volume>
<fpage>329</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="doi">10.1385/NMM:8:3:329</pub-id>
<pub-id pub-id-type="pmid">16775384</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butler</surname>
<given-names>MG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations</article-title>
<source/>J. Med. Genet.
          <year>2005</year>
<volume>42</volume>
<fpage>318</fpage>
<lpage>321</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.2004.024646</pub-id>
<pub-id pub-id-type="pmid">15805158</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lugo</surname>
<given-names>JN</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deletion of PTEN produces autism-like behavioral deficits and alterations in synaptic proteins</article-title>
<source/>Front. Mol. Neurosci.
          <year>2014</year>
<volume>7</volume>
<fpage>27</fpage>
<pub-id pub-id-type="doi">10.3389/fnmol.2014.00027</pub-id>
<pub-id pub-id-type="pmid">24795561</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Praag</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fleshner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Mattson</surname>
<given-names>MP</given-names>
</name>
</person-group>
<article-title>Exercise, Energy Intake, Glucose Homeostasis, and the Brain</article-title>
<source/>J. Neurosci.
          <year>2014</year>
<volume>34</volume>
<fpage>15139</fpage>
<lpage>15149</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2814-14.2014</pub-id>
<pub-id pub-id-type="pmid">25392482</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goodrick</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Ingram</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Cider</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Effects of intermittent feeding upon body weight and lifespan in inbred mice: interaction of genotype and age</article-title>
<source/>Mech. Ageing Dev.
          <year>1990</year>
<volume>55</volume>
<fpage>69</fpage>
<lpage>87</lpage>
<pub-id pub-id-type="doi">10.1016/0047-6374(90)90107-Q</pub-id>
<pub-id pub-id-type="pmid">2402168</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Longo</surname>
<given-names>VD</given-names>
</name>
<name>
<surname>Mattson</surname>
<given-names>MP</given-names>
</name>
</person-group>
<article-title>Fasting: molecular mechanisms and clinical applications</article-title>
<source/>Cell Metab.
          <year>2014</year>
<volume>19</volume>
<fpage>181</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.1016/j.cmet.2013.12.008</pub-id>
<pub-id pub-id-type="pmid">24440038</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fontán-Lozano</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Caloric restriction increases learning consolidation and facilitates synaptic plasticity through mechanisms dependent on NR2B subunits of the NMDA receptor</article-title>
<source/>J. Neurosci.
          <year>2007</year>
<volume>27</volume>
<fpage>10185</fpage>
<lpage>10195</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2757-07.2007</pub-id>
<pub-id pub-id-type="pmid">17881524</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anson</surname>
<given-names>RM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2003</year>
<volume>100</volume>
<fpage>6216</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1035720100</pub-id>
<pub-id pub-id-type="pmid">12724520</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varady</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Hellerstein</surname>
<given-names>MK</given-names>
</name>
</person-group>
<article-title>Alternate-day fasting and chronic disease prevention: a review of human and animal trials</article-title>
<source/>Am. J. Clin. Nutr.
          <year>2007</year>
<volume>86</volume>
<fpage>7</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1093/ajcn/86.1.7</pub-id>
<pub-id pub-id-type="pmid">17616757</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>LAINHART</surname>
<given-names>JE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Macrocephaly in Children and Adults With Autism</article-title>
<source/>J. Am. Acad. Child Adolesc. Psychiatry
          <year>1997</year>
<volume>36</volume>
<fpage>282</fpage>
<lpage>290</lpage>
<pub-id pub-id-type="doi">10.1097/00004583-199702000-00019</pub-id>
<pub-id pub-id-type="pmid">9031582</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<mixed-citation publication-type="other">Napoli, E. <italic>et al</italic>. Mitochondrial dysfunction in Pten Haplo-insufficient mice with social deficits and repetitive behavior: Interplay between Pten and p53. <italic>PLoS One</italic><bold>7</bold> (2012).</mixed-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freeman</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic background controls tumor development in Pten-deficient mice</article-title>
<source/>Cancer Res.
          <year>2006</year>
<volume>66</volume>
<fpage>6492</fpage>
<lpage>6496</lpage>
<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-4143</pub-id>
<pub-id pub-id-type="pmid">16818619</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>White</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lugo</surname>
<given-names>JN</given-names>
</name>
</person-group>
<article-title>Superimposing Status Epilepticus on Neuron Subset-Specific PTEN Haploinsufficient and Wild Type Mice Results in Long-term Changes in Behavior</article-title>
<source/>Sci. Rep.
          <year>2016</year>
<volume>6</volume>
<fpage>36559</fpage>
<pub-id pub-id-type="doi">10.1038/srep36559</pub-id>
<pub-id pub-id-type="pmid">27819284</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogawa</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A seizure-prone phenotype is associated with altered free-running rhythm in Pten mutant mice</article-title>
<source/>Brain Res.
          <year>2007</year>
<volume>1168</volume>
<fpage>112</fpage>
<lpage>123</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2007.06.074</pub-id>
<pub-id pub-id-type="pmid">17706614</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice</article-title>
<source/>J. Neurosci.
          <year>2009</year>
<volume>29</volume>
<fpage>1773</fpage>
<lpage>1783</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5685-08.2009</pub-id>
<pub-id pub-id-type="pmid">19211884</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carola</surname>
<given-names>V</given-names>
</name>
<name>
<surname>D’Olimpio</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Brunamonti</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mangia</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Renzi</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice</article-title>
<source/>Behav. Brain Res.
          <year>2002</year>
<volume>134</volume>
<fpage>49</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="doi">10.1016/S0166-4328(01)00452-1</pub-id>
<pub-id pub-id-type="pmid">12191791</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anchan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pollard</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Vasudevan</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>GPR30 activation decreases anxiety in the open field test but not in the elevated plus maze test in female mice</article-title>
<source/>Brain Behav.
          <year>2014</year>
<volume>4</volume>
<fpage>51</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1002/brb3.197</pub-id>
<pub-id pub-id-type="pmid">24653954</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramos</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Animal models of anxiety: do I need multiple tests?</article-title>
<source/>Trends Pharmacol. Sci.
          <year>2008</year>
<volume>29</volume>
<fpage>493</fpage>
<lpage>498</lpage>
<pub-id pub-id-type="doi">10.1016/j.tips.2008.07.005</pub-id>
<pub-id pub-id-type="pmid">18755516</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gross</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Canteras</surname>
<given-names>NS</given-names>
</name>
</person-group>
<article-title>The many paths to fear</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2012</year>
<volume>13</volume>
<fpage>651</fpage>
<lpage>658</lpage>
<pub-id pub-id-type="doi">10.1038/nrn3301</pub-id>
<pub-id pub-id-type="pmid">22850830</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<mixed-citation publication-type="other">Kalueff, A. V. Neurobiology of memory and anxiety: From genes to behavior. <italic>Neural Plast</italic>. <bold>2007</bold> (2007).</mixed-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<mixed-citation publication-type="other">Zablotsky, B., Black, L. I., Maenner, M. J., Schieve, L. A. &amp; Blumberg, S. J. Estimated Prevalence of Autism and Other Developmental Disabilities Following Questionnaire Changes in the 2014 National Health Interview Survey. <italic>Natl</italic>. <italic>Heal</italic>. <italic>Stat</italic>. <italic>Rep</italic>. 1–19 (2015).</mixed-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clipperton-Allen</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Page</surname>
<given-names>DT</given-names>
</name>
</person-group>
<article-title>Pten haploinsufficient mice show broad brain overgrowth but selective impairments in autism-relevant behavioral tests</article-title>
<source/>Hum. Mol. Genet.
          <year>2014</year>
<volume>23</volume>
<fpage>3490</fpage>
<lpage>3505</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddu057</pub-id>
<pub-id pub-id-type="pmid">24497577</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mattson</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems</article-title>
<source/>Journal of Nutritional Biochemistry
          <year>2005</year>
<volume>16</volume>
<fpage>129</fpage>
<lpage>137</lpage>
<pub-id pub-id-type="doi">10.1016/j.jnutbio.2004.12.007</pub-id>
<pub-id pub-id-type="pmid">15741046</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Texel</surname>
<given-names>SJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ceruloplasmin deficiency results in an anxiety phenotype involving deficits in hippocampal iron, serotonin, and BDNF</article-title>
<source/>J. Neurochem.
          <year>2012</year>
<volume>120</volume>
<fpage>125</fpage>
<lpage>134</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2011.07554.x</pub-id>
<pub-id pub-id-type="pmid">22035068</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawamoto</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Scavone</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mattson</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Camandola</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Curcumin requires tumor necrosis factor? signaling to alleviate cognitive impairment elicited by lipopolysaccharide</article-title>
<source/>NeuroSignals
          <year>2013</year>
<volume>21</volume>
<fpage>75</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="doi">10.1159/000336074</pub-id>
<pub-id pub-id-type="pmid">22572473</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaw</surname>
<given-names>KN</given-names>
</name>
<name>
<surname>Commins</surname>
<given-names>S</given-names>
</name>
<name>
<surname>O’Mara</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>Lipopolysaccharide causes deficits in spatial learning in the watermaze but not in BDNF expression in the rat dentate gyrus</article-title>
<source/>Behav. Brain Res.
          <year>2001</year>
<volume>124</volume>
<fpage>47</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="doi">10.1016/S0166-4328(01)00232-7</pub-id>
<pub-id pub-id-type="pmid">11423165</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okun</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Toll-like receptor 3 inhibits memory retention and constrains adult hippocampal neurogenesis</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2010</year>
<volume>107</volume>
<fpage>15625</fpage>
<lpage>15630</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1005807107</pub-id>
<pub-id pub-id-type="pmid">20713712</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vasconcelos</surname>
<given-names>AR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intermittent fasting attenuates lipopolysaccharide-induced neuroinflammation and memory impairment</article-title>
<source/>J. Neuroinflammation
          <year>2014</year>
<volume>11</volume>
<fpage>85</fpage>
<pub-id pub-id-type="doi">10.1186/1742-2094-11-85</pub-id>
<pub-id pub-id-type="pmid">24886300</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bradford</surname>
<given-names>MM</given-names>
</name>
</person-group>
<article-title>A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</article-title>
<source/>Anal. Biochem.
          <year>1976</year>
<volume>72</volume>
<fpage>248</fpage>
<lpage>254</lpage>
<pub-id pub-id-type="doi">10.1016/0003-2697(76)90527-3</pub-id>
<pub-id pub-id-type="pmid">942051</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laemmli</surname>
<given-names>UK</given-names>
</name>
</person-group>
<article-title>Cleavage of structural proteins during the assembly of the head of bacteriophage T4</article-title>
<source/>Nature
          <year>1970</year>
<volume>227</volume>
<fpage>680</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1038/227680a0</pub-id>
<pub-id pub-id-type="pmid">5432063</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>